martindale.com
Legal Library
|
Norton Rose Canada LLP Toronto, ON Document Search Results (55) Show: results per page Sort by:  | Flow-Through Shares for the Innovation Sector
Richard S. Sutin; Norton Rose Canada LLP;
Legal Alert/Article June 1, 2012, previously published on May 2012 Underlying the current financial crisis, developed economies continue to struggle with the twin challenges of a disruptive global re-ordering and the transition from industrial to knowledge-based economies. Given the huge impact on future jobs and prosperity, policy-makers have recognized the need...
| | Amendments to the Investment Canada Act Intended to Increase Transparency
Kevin Ackhurst; Norton Rose Canada LLP;
Legal Alert/Article May 17, 2012, previously published on May 2012 On April 27, 2012, the federal government announced it would amend the Investment Canada Act to allow the minister of industry greater flexibility in explaining why a proposed foreign takeover of a Canadian business raises preliminary concerns. The amendments, contained in the government’s...
| | "Poking" Around Facebook: Employers Thinking About Requesting Employee Passwords Should Be Aware of Canadian Privacy Laws
Arnaud Gingras-Tremblay, Pierre-Étienne Morand, Pamela Sidey; Norton Rose Canada LLP;
Legal Alert/Article May 9, 2012, previously published on May 2012 The emerging practice in the United States of employers asking for Facebook login details from prospective employees has prompted significant controversy. Some companies have made other requests such as asking job applicants to log in to their private profiles during interviews or become Facebook...
|  | Pharma in Brief - Canada: Federal Court of Appeal Upholds Compound Claim Based on a Promise of Enzymatic Inhibition [ARIMIDEX® (Anastrozole)]
Jason Markwell, Judith Robinson; Norton Rose Canada LLP;
Legal Alert/Article May 7, 2012, previously published on May 2012 In 2007, the Minister placed sanofi’s drug Eloxatin® on the Register of innovative drugs (“Register”) under C.08.004.1(9) of the Food and Drug Regulations, C.R.C., c. 870 (the “Regulations”).
| | Securities in Brief - Canadian Legislative Framework Introduced for Covered Bonds
Andrew Fleming, Peter S. Noble, Eric Reither; Norton Rose Canada LLP;
Legal Alert/Article May 1, 2012, previously published on May 2012 On April 26, 2012 the Canadian government introduced legislation which provides a framework for the issuance of covered bonds by Canadian financial institutions. The framework is intended to make the market for Canadian covered bonds more robust and increase financial stability by helping lenders...
| | Federal Court of Appeal Holds That Prior SAP Authorization Does Not Prevent Minister from Granting Data Protection (ELOXATIN®)
Daniel Daniele; Norton Rose Canada LLP;
Legal Alert/Article April 27, 2012, previously published on April 2012 In 2007, the Minister placed sanofi’s drug Eloxatin® on the Register of innovative drugs (“Register”) under C.08.004.1(9) of the Food and Drug Regulations, C.R.C., c. 870 (the “Regulations”).
| | Club Resorts Ltd. v Van Breda: The Supreme Court of Canada Considers the Test for Jurisdiction
Rahool P. Agarwal, Ilana Schrager; Norton Rose Canada LLP;
Legal Alert/Article April 24, 2012, previously published on April 2012 The Supreme Court of Canada’s decision in Club Resorts Ltd. v Van Breda addresses the legal test for when a Canadian court should assume jurisdiction over an out-of-province defendant.
| | Adventure Company Can’t Jump the Gap in Trade-Mark Dispute
Adam Haller; Norton Rose Canada LLP;
Legal Alert/Article April 19, 2012, previously published on April 2012 Canadian sustainable-travel company, G.A.P. Adventures Inc. (“G.A.P. Adventures”, now known as G Adventures), has suffered another blow in the latest round of its trade-mark dispute with American retail giant, The Gap, Inc. (“The Gap”)
| | First Phase of CSA’s Investment Fund "Modernization Project" Comes into Force April 30
Michael Bunn; Norton Rose Canada LLP;
Legal Alert/Article April 16, 2012, previously published on April 2012 On April 30, 2012, amendments (the Amendments) will be made to the following National Instruments as part of the Canadian Securities Administrators (CSA) project to modernize the product regulation of publicly offered investment funds (the Modernization Project):
| | Ontario Superior Court Rules on Priorities in Insolvency Proceedings of Environmental Orders for Historical Contamination
Nicholas D.W. Daube, Alan B. Merskey; Norton Rose Canada LLP;
Legal Alert/Article April 12, 2012, previously published on April 2012 The Ontario Superior Court of Justice (Commercial List) has confirmed that historical environmental remediation obligations will not automatically take priority over the claims of other creditors in an insolvency, even where those obligations are framed in the form of regulatory orders.
|
|